Patients' reports of their experience with illness are a key health outcome, but scores that measure these reports can be difficult to interpret. Skindex-29 measures skin-related quality of life reliably and validly. In this issue, Prinsen and colleagues compare patients' responses to "anchor" questions with their Skindex scores to derive clinically meaningful scores for the subscales of Skindex-29. The cutoff scores identify patients whose skin diseases severely affect their quality of life.
Because hair follicles originate within an organ whose primary role is barrier to water loss, one would assume that hair follicle structure and function must also be dominated by lipid components: lipids to repel water, lipids to maintain the permeability barrier, lipids to maintain structure, and lipid messengers. Yet, when serious attention is given to this deceptively simple appendage, the focus is usually on its protein structure and peptide signaling. Where lipids have been implicated in hair follicle pathology, the findings have been made serendipitously (e.g., Sundberg et al., 2000; Moulson et al., 2003; Westerberg et al., 2004; Lee et al., 2007; Shimomura et al., 2009) , without a deep understanding of the finding within the big picture. For those of us who live with the follicle, it is satisfying to note that in the past 3 years as many papers have appeared describing fundamental lipid pathways, which, when perturbed, cause severe hair follicle injury.
In 2007 Wan et al. described a mammary gland-specific peroxisome proliferator-activated receptor-γ (PPARγ) knockout mouse that showed no phenotype itself. But pups suckling on the mutant dam developed an alopecia induced by oxidized lipids carried in the milk. Once weaned and freed of the toxin-containing milk, the pups regained their hair. The affected skin exhibited abnormal follicle growth and cycling, dilated pilary canals, follicle arrest in an abnormal catagen/ telogen, and a dermis housing inflammatory cells. The contribution made by Karnik et al. (2009) related to the association of PPARγ deficiency with a form of human cicatricial alopecia. By gene array analysis and real-time PCR, this group demonstrated the downregulation of PPARγ and PPARγ-regulated genes required for cholesterol biosynthesis, lipid metabolism, and peroxisome biogenesis in patients with lichen planopilaris (LPP). When these investigators knocked out PPARγ expression in the stem cells of mouse hair follicles, not only did the mutation recapitulate many of the gene expression and histological findings of LPP, it also induced follicle cyst formation, dystrophic catagen/telogen forms, and dermal inflammation.
The current issue of the Journal of Investigative Dermatology features work from a group with long-term interest in cholesterol metabolism. Cholesterol has been suspected of playing a role in normal hair biology, as illustrated by the hair loss suffered by some patients taking cholesterol-reducing statins. In the current study, Evers et al. (2010) asked the inverse question. They studied the effect of an upregulated cholesterol synthesis pathway in mouse hair follicles by knocking out the expression of Insig proteins, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase, the rate-limiting enzyme of cholesterol biosynthesis.
Insig proteins normally control cholesterol synthesis by decreasing it whenever sterol levels are high. In this model, sterol precursors accumulated in the hair follicle epithelium, causing distortion of whiskers and hair shafts; ectatic, keratin-plugged distal follicles; and abnormally arrested catagen/telogen forms.
The approaches taken in the three studies have fundamental differences, such as in the expression site of the hair follicle mutation: the mammary gland, hair follicle stem cell lineage, and epidermis and hair follicle sheath. The cells expressing the mutation also differ: endothelial/hematopoietic cells (Wan et al., 2007) , hair follicle epithelial stem cells (Karnik et al., 2009) , and oral epithelium/epidermis/hair follicle outer root sheath (Evers et al., 2010) . Nonetheless, many of the changes observed are remarkably similar. For example, hair shaft distortion, distal follicle ectasia (pseudocyst), keratin plugging of the pilary canal, dystrophic catagen/telogen forms, and dermal inflammation are found to a variable degree in all three studies. In addition, the phenotype in the first two studies is dramatically reversible, so, despite significant follicle distortion, under the proper rescue therapy normal follicles reform, a feature no doubt reflecting the regenerative power of the follicle itself.
Equating the phenotypic similarities of the three mutants with the data at hand may perhaps be a stretch in logical thought, although the downstream factors accumulating in the absence of PPARγ are common, including the upregulated prostaglandin and lipoxygenase pathways and downregulated lipid metabolic pathways. None of the studies defines a mechanism to explain how the cellular follicular changes occur: why do the distal follicles dilate, why does the follicle lumen fill with keratin, why do the hairs crimp? What causes dermal inflammation? What is the link between altered lipid metabolism, inflammation, and disrupted hair follicles? The three studies clearly show an apparent toxic effect on hair follicle cycling-the pathology is clear. The role of these lipid metabolic pathways in normal hair follicle biology and the mechanism by which changes in these pathways cause the pathological phenotype remain unclear, and such questions need attention. A trivial explanation for the common features of the variants in these reports might be that upon insult the hair follicle can muster only one, or a few, cell responses to injury. One such response would be the inflammation induced by proinflammatory lipids or sterols. We now know that there is an extensive, delicately balanced interaction between the immune and metabolic pathways, an interaction that is dysfunctional in chronic metabolic diseases such as type 2 diabetes and atherosclerosis (Hotamisligil, 2006; Wellen et al., 2007) . Although there are short-term compensatory and adaptive measures that keep this delicate balance in check, the outcome could be detrimental if one arm overwhelmed the other in the long run. For example, Karnik et al. (2009) have reported that LPP includes a chronic disturbance of metabolic homeostasis in hair follicle cells due to inactivation of PPARγ. The PPAR and liver X receptor families of transcription factors seem to be crucial for modulating the intersection of metabolic and inflammatory pathways (Bensinger and Tontonoz, 2008) . Activation of these transcription factors inhibits the expression of several genes involved in the inflammatory response, with the implication that loss of activation of these factors will not only disturb metabolic homeostasis but also induce inflammatory damage to tissues, such as the hair follicle.
A second cellular response to disturbed lipid homeostasis could be organelle stress. The endoplasmic reticulum (ER), mitochondria, and peroxisomes are important sites for the metabolism of lipids, especially phospholipids and cholesterol, and for the monitoring of their intracellular status (Murphy et al., 2009) . For example, cholesterol sensing is initiated at the ER membrane through the transcription factor sterol-regulatory-elementbinding protein (Colgan et al., 2007) . Organelle stress induced by chronic disturbance of metabolic homeostasis in hair follicle cells could lead to the generation of reactive oxygen species by the ER and mitochondria, leading to activation of stress and inflammatory signaling cascades and oxidative damage (Ron and Walter, 2007; Todd et al., 2008) . If ER and mitochondrial homeostasis were not restored, the organelles could activate apoptotic pathways in the hair follicle, destroying it.
A third mechanism linking lipid homeostasis to the hair follicle is lipid modification of signaling proteins such as Hedgehogs (Hhs) and Wnts, which are necessary for hair follicle morphogenesis and cycling. The N-terminus of Hh becomes modified by the fatty acid palmitate on a conserved cysteine residue, whereas the C terminus is cholesterol modified. Wnt molecules are palmitoylated on the first conserved cysteine (C77), a residue that is present on all Wnts. Genetic data suggest that lipid modification localizes the Wnt and Hh proteins to membranes, a requirement for Wnt and Hh protein activity (Nusse, 2003) . A site-directed mutation in one of the endogenous Hh genes in the mouse (sonic hedgehog) demonstrated that loss of cholesterol modification attenuates the range of Hh activity, and perhaps even a loss, of Hh activity (Lewis et al., 2001 A parallel for some of the pathological changes described in these models can be found in several forms of clinical cicatricial alopecia as well as in acne vulgaris. On the basis of the observations reported by Evers et al., we would predict that lipids play a significant role in hair follicle morphogenesis and cycling and that alterations in lipid pathways underlie many clinical hair follicle disorders.
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The writing of this Commentary was made possible in part by research grants from the Cicatricial Alopecia Research Foundation and NIH-NIAMS grant R01 AR056245 to PK. Bazan JF, deSauvage FJ (2009) For many measurements in clinical studies we lack this intuition, however. One of the original studies of finasteride for benign prostatic hyperplasia graphically illustrates this point (Lydick and Epstein, 1993; Gormley et al., 1992) . Compared with placebo, the drug improved urine flow by an average of 3 ml/second-a rather bland finding, to be sure-until a subsequently published epidemiological study found that for men aged 40-74 typical urine flow rates decline approximately 0.2-0.3 ml/ second per year of life (Girman et al., 1993) . We can now interpret the realworld effect of finasteride: on average, it restores a man's urinary flow to what it was 10-15 years earlier.
ReFeReNCeS
Interpreting measurements such as urine flow is relatively straightforward compared with interpreting more abstract health outcomes such as scores of patients' reports concerning their experience with illness. The actual measurement of psychometric constructs is a highly advanced and rigorous science, and substantial progress has been made in applying this science to clinical medicine (Both et al., 2007) . Dermatology has lagged somewhat in rigorous studies to interpret the meaning of psychometric scores, however, and these scores remain unfamiliar to most researchers and clinicians. It is highly fitting that in what the Journal has designated the Year of the Patient (Bergstresser, 2010) , this issue contains a good example of a study to facilitate interpretation of one measurement of patients' experience of illness (Prinsen et al., 2010) . In this Commentary, I describe briefly where we are with respect to measuring patients' reports, summarize the major findings of that article, and project where we might go next to advance this important aspect of clinical research.
Patients' reports of their experience with illness are a key health outcome. This observation is especially true for skin diseases, which do not typically affect survival, laboratory values, or easily measured clinical changes. In fact, patients' reports are arguably an essential health outcome for dermatology because skin diseases (unlike most "internal" diseases) can change appearance, and they may have psychological and functional effects that cannot be assessed except through patients' reports.
Most scientific work on the assessment of patients' experience with cutaneous illness has focused on instruments that measure skin-related quality of life. Generic and disease-specific quality-oflife instruments have been developed
